Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $11.1M | $170K | $8.00K | $8.00K |
| Revenue growth | — | -98.5% | -95.3% | 0.0% |
| Operating income | -$3.01M | -$24.2M | -$31.7M | -$33.2M |
| Operating margin | -27.2% | -14214.7% | -396200.0% | -415175.0% |
| Net income | -$5.21M | -$28.3M | -$29.9M | -$32.1M |
| Net margin | -47.0% | -16645.3% | -373362.5% | -401812.5% |
| EPS (diluted) | -$0.57 | -$1.16 | -$0.95 | -$0.86 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$3.57M | -$20.3M | -$21.2M | -$25.3M |
| Capital expenditures | $49.0K | $1.02M | $381K | $1.10M |
| Free cash flow | -$3.62M | -$21.3M | -$21.6M | -$26.4M |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $397K | $9.42M | $8.56M | $5.33M |
| Total assets | $5.53M | $27.9M | $34.7M | $19.0M |
| Total liabilities | $41.3M | $8.42M | $8.44M | $7.48M |
| Shareholders' equity | -$35.8M | $19.5M | $26.3M | $11.5M |
| Retained earnings | -$190M | -$222M | -$251M | -$284M |
| Shares (wtd avg diluted) | 9.12M | 24.4M | 31.5M | 37.2M |
Every figure is extracted from GENELUX Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.